Ann: ATL1102 Clinical Trial Update, page-9

Hey Pump - The trial extension is planned for all patients. That is, to continue on the drug after the initial closed-label six months.

There are some that will not have received the active drug, and have just been taking a placebo during this first six months of the trial. The extension means that every boy will actually have a chance to take the actual drug.

It is a great result if they continue on with the drug in the open-label extension. In my mind it means the boys and their carers are seeing a positive result
- there is more data available over a longer period of time.